Hopital NOVO — Clinical Trial Site

76 Registered trials

35 Currently recruiting

Organisation

Hopital NOVO

Location

Pontoise, France

Identifier

ORG-100043308

Address

6 Avenue De L Ile De France, 95300, France

Departments

Cardiologie
Cardiology/EP
chirurgie digestive
Chirurgie viscérale et digestive
Departement d'endocrinologie
Département d'hématologie
ENT Department
Gynaecology-Obstetrics
Gynecology-obstetric
Hématologie
Hématologie et de Thérapie Cellulaire
hématologie et thérapie cellulaire
Hematology
Hematology department
Hopital NOVO - Site de Pontoise
Hopital NOVO ? site de Pontoise (#1)
Medical Oncology
N/A
Néonatologie
Nephrology
NEUROLOGIE
Nuclear Medicine
Obstetric gynecology
Onco-hématologie
Oncologie
Oncology
Oncology Department
Ophthalmology
Pédiatrie
Pneumologie
Pneumology
Réanimation
Réanimation et médecine néonatale
Rhumatologie
SAMU 95
Service cardiologie
Service Chirurgie cervico faciale et ORL
Service d'hématologie clinique
Service d’Oncologie
Service de Néphrologie et Dialyses
Service de Pneumologie
Service Hématologie
Service Hematologie Clinique et Therapie Cellulaire
SMUR Urgences adultes - CH René Dubois Pontoise
SMUR Urgences adultes - Site Beaumont
Urologie
Urology

Clinical trials at this site (76)

Search interface

Decreasing treatment for metastatic HER2-Positive Breast Cancer with undetectable cancer levels in blood tests Recruiting

2023-509811-98-00 Patients with HER2-positive locally advanced inoperable 4 2025-01-07
Acute non-severe osteomyelitis in children Recruiting

2024-516744-26-00 acute osteomyelitis of the child 4 2024-11-15
Immunotherapy and chemotherapy treatment or no treatment guided by the level of tumour-infiltrating cells in resected early-stage triple-neg… Recruiting

2023-504620-26-00 Triple negative breast cancer 4 2024-11-04
QUIDOSE. Randomized controlled trial testing the efficacy of hydroxychloroquine combined with low dose corticosteroid therapy in pulmonary s… Recruiting

2024-516101-23-00 Sarcoidosis 5 2024-10-28
Comparison of Two Antibiotic Regimens for the Treatment of Early Airways Infection With PA in Adults With Bronchiectasis Recruiting

2023-504755-26-00 Bronchiectasis 4 2024-10-21
FLUOCOL-1 : Intraoperative Indocyanine Green Fluorescence Angiography in Colorectal Surgery to Prevent Anastomotic Leakage Recruiting

2024-515118-42-00 Colorectal cancer 11 2024-09-10
A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Lisaftoclax (APG-2575) in Previously Treated Patients with Chro… Recruiting

2023-508005-24-00 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 5 2024-08-01
Tocolysis in cases of preterm premature rupture of membranes (PPROM) before 34 weeks of gestation: a double-blinded randomized controlled tr… Recruiting

2024-512872-36-00 obstetric_pathological delivery 5 2024-07-25
PRODIGE 87 FOXTROT II : Personalising and refining neo-adjuvant chemotherapy in locally advanced but resectable colon cancer in the elderly … Recruiting

2023-505214-23-00 colon carcinoma 5 2024-06-07
C1071032 - MAGNETISMM-32 A PHASE 3, OPEN-LABEL STUDY OF ELRANATAMAB MONOTHERAPY VERSUS ELOTUZUMB, POMALIDOMIDE, DEXAMETHASONE (EPd) OR POMAL… Recruiting

2023-507871-23-00 Relapsed/Refractory Multiple Myeloma 5 2024-05-27
A Randomized, Multicenter, Placebo-controlled, Phase 3 study to Evaluate the Efficacy and Safety of HER2/neu Peptide GLSI-100 (GP2 + GM-CSF)… Recruiting

2023-504323-25-01 breast cancer 5 2024-03-19
Frexalimab in preservation of endogenous insulin secretion compared to placebo in adults, adolescents and children on top of Insulin therapy… Recruiting

2022-500531-36-00 Type 1 diabetes mellitus 4 2024-02-02
A Trial to Learn if Odronextamab Combined with Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined … Recruiting

2022-502113-28-00 Follicular lymphoma 5 2024-02-01
EvER-ILD 2: Evaluation of Efficacy and safety of Rituximab in patients with progressive Interstitial Lung Disease (ILD) with inflammatory co… Recruiting

2022-501335-16-00 Interstitial lung disease 10 2023-01-16
Effectiveness of an Optimisation Strategy for Emergency Tracheal Intubation on postintubation Morbidity: A superiority cluster randomised co… Recruiting

2024-514913-37-00 Respiratory distress 11 2023-01-12
A randomized phase I/ II multicenter study evaluating combination of luspatercept in LR-MDS without RS having failed or being ineligible to … Recruiting

2024-515354-24-00 Low risk myelodysplastic syndrom without RS having fail 9 2022-05-18
Oxytocin versus Prostaglandins for labor Induction of women with an unfavorable Cervix after 24 hours of cervical ripening: a multicenter no… Recruiting

2024-517675-20-00 Labor Induction of women with an unfavorable Cervix aft 11 2021-09-28
Short Treatment With Omalizumab for Severe Asthma (SHORTEN) Recruiting

2024-513427-17-00 Well controlled severe allergic asthma 6 2021-05-20
A Phase III trial of acetylsalicylic acid and atorvastatin in patients with castrate-resistant prostate cancer (PEACE 4) Recruiting

2023-508072-11-00 Castration-resistant prostate cancer 5 2019-06-26
CLAZI : CLArithromycin versus AZIthromycin in the treatment of Mycobacterium avium complex pulmonary infections: A randomized prospective co… Recruiting

2024-518578-15-00 Is to demonstrate a non inferior efficacy of azithromyc 5 2018-02-05
Phase 3 trial aimed at improving the overall survival of AML in adults aged 18 to 60 by comparing high-dose idarubicin with daunorubicin at … Ended

2024-516873-57-00 Acute myeloid leukemia in adults aged 18 to 60 10 2026-01-13
A Phase 3 study to assess the efficacy, safety, and tolerability of itepekimab (antiIL33 mAb) in participants with inadequately-controlled… Ended

2024-516815-26-00 Chronic rhinosinusitis with nasal polyps 5 2025-05-30
DAPAgliflozine to attenuate cardiac RemOdeling afTEr aCuTe myOcardial infarction Ended

2024-511882-13-01 Cardiac failure 5 2024-11-19
STUDY AGORA-1 / ALFA 2100: Phase 2 on the combinaison of Gemtuzumab Ozogamicin witk gilteritinib in adult patients with acute myeloid leukem… Ended

2023-504176-25-00 Acute Myeloid Leukemia 9 2024-08-08